title: Editorial: Should We Abandon TNM Staging in Favor of Gene Profiles in Node-Positive Melanoma?
authors.affiliation: Surgical Outcomes and Quality Improvement Center (SOQIC), Department of Surgery and Center for Healthcare Studies, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.|Center for Healthcare Studies, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
authors.forename: Kathryn E
authors.initials: KE
authors.lastname: Engelhardt
authors.affiliation: Department of Surgery, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
authors.forename: Jeffrey D
authors.initials: JD
authors.lastname: Wayne
authors.affiliation: Surgical Outcomes and Quality Improvement Center (SOQIC), Department of Surgery and Center for Healthcare Studies, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. kbilimoria@nm.org.|Center for Healthcare Studies, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. kbilimoria@nm.org.|Department of Surgery, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. kbilimoria@nm.org.|Northwestern Institute for Comparative Effectiveness Research (NICER) in Oncology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. kbilimoria@nm.org.
authors.forename: Karl Y
authors.initials: KY
authors.lastname: Bilimoria
mesh_terms: D014408:Biomarkers, Tumor / Q000235:genetics*; D006801:Humans; D008207:Lymphatic Metastasis; D008545:Melanoma / Q000145:classification* / Q000235:genetics / Q000473:pathology; D009367:Neoplasm Staging; D011379:Prognosis; D059467:Transcriptome
chemical_list: D014408:Biomarkers, Tumor